Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 1—January 2021
Research

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines

Shalom Ben-Shimol, Noga Givon-Lavi, Leore Kotler, Bart Adriaan van der Beek, David Greenberg, and Ron DaganComments to Author 
Author affiliations: Ben-Gurion University of the Negev, Beer Sheva, Israel (S. Ben-Shimol, N. Givon-Lavi, L. Kotler, B.A. van der Beek, D. Greenberg, R. Dagan); Soroka University Medical Center, Beer Sheva (S. Ben-Shimol, N. Givon-Lavi, L. Kotler, D. Greenberg)

Main Article

Table 2

Proportions of VT20–13/NVT20 ratios in children age <24 mo, Israel, 2009–2011 and 2015–2017*

Clinical characteristic 2009–2011

2015–2017

2015–2017 vs. 2009–2011
VT20–13, % NVT20, % VT20–13/NVT20 ratio (95% CI) VT20–13, % NVT20, % VT20–13/NVT20 ratio (95% CI) VT20–13/NVT20 ratio (95% CI)
Carriage in healthy children NA NA NA 24 66 0.37 (0.33–0.41) NA
Carriage in non-LRTI 18 38 0.46 (0.38–0.56) 23 66 0.35 (0.30–0.40) 0.80 (0.65–0.98)
Conjunctivitis 20 34 0.60 (0.39–0.91) 19 72 0.26 (0.17–0.40) 0.57 (0.35–0.94)
Carriage in LRTI 13 34 0.39 (0.30–0.50) 32 57 0.56 (0.48–0.65) 1.26 (1.00–1.60)
OM 14 21 0.68 (0.49–0.94) 34 52 0.60 (0.44–0.81) 0.91 (0.66–1.25)
IPD 15 13 1.19 (0.79–1.80) 52 38 1.40 (1.12–1.73) 1.05 (0.84–1.31)

*No data were available for healthy children in 2009–2011. IPD, invasive pneumococcal disease; LRTI, lower respiratory tract infection; NA, not applicable; NVT20, serotypes not included in PCV20; OM, otitis media; PCV, pneumococcal conjugate vaccine; VT20–13, additional 20-valent PCV (PCV20) serotypes, not included in PCV13.

Main Article

Page created: November 19, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external